|
Status |
Public on Jun 23, 2020 |
Title |
MC2494 rep2 |
Sample type |
RNA |
|
|
Source name |
acute myeloid leukemia
|
Organism |
Homo sapiens |
Characteristics |
treatment: MC2494 cell line: U937
|
Treatment protocol |
U937 clls were treated with the compounds for 24h
|
Growth protocol |
U937 cells were cultured in RPMI medium supplemented with 2 mM glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA extracted using TRIZOL (Invitrogen) reagent following manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
3000ng of total RNA were converted in cDNA and then in cRNA following manufacturer's instruction.
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
chip were scanned with Illumina BeadArray Reader, BeadScan software version 3.5.49
|
Description |
replicate 2 SAMPLE 10
|
Data processing |
The data were normalised using quantile normalisation with limma package in R
|
|
|
Submission date |
Jun 25, 2013 |
Last update date |
Jun 23, 2020 |
Contact name |
Annamaria Carissimo |
E-mail(s) |
carissimo@tigem.it
|
Organization name |
Tigem
|
Street address |
via Castellino
|
City |
Napoli |
ZIP/Postal code |
80131 |
Country |
Italy |
|
|
Platform ID |
GPL6883 |
Series (1) |
GSE48295 |
Genes differentially expressed in human AML cells after treatment with a novel SirTi, MC2494. |
|